ingenuity pathway analysis ipa (Qiagen)
Structured Review

Ingenuity Pathway Analysis Ipa, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ingenuity+pathway+analysis+(ipa)/ingenuity+pathway+analysis/pmc12276267-129-11-16
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Uncovering the molecular signature of feline diffuse iris melanoma through transcriptomic analysis of disease severity"
Article Title: Uncovering the molecular signature of feline diffuse iris melanoma through transcriptomic analysis of disease severity
Journal: Scientific Reports
doi: 10.1038/s41598-025-09632-5
Figure Legend Snippet: Transcriptomic analysis of feline diffuse iris melanoma (FDIM). The principal component analysis (PCA) plot grouping samples by the top 500 transcripts after variance-stabilising transformation of transcript counts ( A ). There is clear and separate clustering of the iris melanosis and late FDIM samples, with the early FDIM samples overlapping both groups, showing that early FDIM is an intermediate disease stage. Volcano plots highlight the number of significantly dysregulated transcripts between early FDIM and iris melanosis ( B i), late FDIM and iris melanosis ( C i) and between late and early FDIM ( D i). A logfold-change threshold was set at − 1.5 and 1.5 and an adjusted P-value threshold of 0.05 was used. Ingenuity pathway analysis identified cancer and organismal injury and abnormalities to be the top dysregulated disease pathways between early FDIM and iris melanosis ( B ii), late and iris melanosis ( C ii) and late and early FDIM ( D ii). The disease progression of FDIM is associated with key molecular events ( E ). Tumour initiation is associated with upregulation of STOX1, PEG3, XIAP and VIM , increasing invasive tendencies and immune cell recruitment. Progression to late FDIM is characterised by downregulation of SOX11, FOXC1 and FOXC2 , likely leading to a more dedifferentiated and plastic cellular phenotype. Significant upregulation of BIRC2 and BIRC5 leads to inhibition of apoptosis. Additionally, upregulation of BIRC5, CCL2 and HAVCR2 lead to immune-microenvironment remodelling, associated with the M2 (immunosuppressive) tumour associated macrophages as well as T-regulator (Treg) cells and inhibition of cytotoxic T-cells (CTC), aiding immune escape. Created in BioRender. Kayes, D. (2025) https://BioRender.com/m39r385 .
Techniques Used: Transformation Assay, Biomarker Discovery, Inhibition
Related Articles
Indirect Immunoperoxidase Assay:Article Title: High-throughput transcriptomics analysis of equipotent and human relevant mixtures of BPA alternatives reveal additive effects in vitro. Article Snippet: .. Article Title: Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting anti-tumor immunity Article Snippet: .. Article Title: NEDDylation Regulates CD8 + T-cell Metabolism and Antitumor Immunity Article Snippet: .. Article Title: Uncovering the molecular signature of feline diffuse iris melanoma through transcriptomic analysis of disease severity Article Snippet: .. Article Title: The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields). Article Snippet: .. Canonical pathways, upstream regulators analysis and drug analysis Ingenuity canonical pathways and upstream regulators analysis (including drug analysis) were done using Article Title: BDNF-DT and BDNF-AS-DT : Novel Genes in the BDNF locus Article Snippet: .. We investigated whether these four sets of genes are enriched for particular biological features, using QIAGEN’s Article Title: Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids Article Snippet: .. Article Title: Biomimetic Catechol-Incorporated Polyacrylonitrile Nanofiber Scaffolds for Tissue Engineering of Functional Salivary Glands Article Snippet: .. RNA Expression:Article Title: Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting anti-tumor immunity Article Snippet: .. |

